Published in Vaccine Weekly, September 2nd, 2009
"Renewed optimism for the therapeutic potential of immune therapy is currently driven by key advances in tumor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2009-09-02)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.